The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Related Articles
FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
Profiling the developing brain enabled rationally guided modeling of FOXR2-activated CNS neuroblastoma, providing a strategy to overcome the heterogeneous origins of pediatric brain tumors that…
H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
Cell persistence and senescence are distinct states of proliferative arrest induced by cancer therapy, with persister cells being characterized by the silencing of inflammatory genes…
Biomarkers of Nicotine and Toxicant Exposure by E-Liquid Nicotine Concentration Level among US Adult Exclusive E-Cigarette Users
AbstractBackground:. The current e-cigarette market has been rapidly evolving with an increase in the share of high nicotine concentration vaping products. This study examined urinary…
AACR Journals Editors’ Picks | American Association for Cancer Research
AACR Journals Editors’ Picks | American Association for Cancer Research h1#page-title { display: none; } h3 a:link{font-weight: 700;} h4{margin-top: 20px; margin-bottom: 0; font-size: 1.2em;} .indent…
Tucatinib Combo Shows Meaningful Activity in HER2+ Metastatic Breast Cancer
Tucatinib plus trastuzumab was well tolerated in patients with metastatic breast cancer and consistent with the combination’s established safety profile.
5th How to Diagnose and Treat: Multiple Myeloma | ESH – European School of Haematology
Chairs : Hermann Einsele, Maria Theresa Krauth, Maria Victoria Mateos, Omar Nadeem April 3-5, 2025 – Vienna, Austria Chairs: Hermann Einsele, Maria Theresa Krauth, Maria-Victoria…
Amethyst Radiotherapy UK achieves 84% patient growth – Oncology Today
Amethyst Radiotherapy UK has announced an impressive 84 per cent growth in the number of patients treated in 2024 compared to 2020 when Amethyst Healthcare…
Improving postsurgical paresis in brain tumor patients by transcranial magnetic stimulation
Journal of Neuro-Oncology – Recently, reduction of transcallosal inhibition by contralateral navigated repetitive transcranial magnetic stimulation (nrTMS) improved neurorehabilitation of glioma…
Alcohol and cancer risk
A new federal advisory indicates there’s no safe level of regular alcohol use when it comes to cancer risk. Experts at the @OSUCCC_James explain what…
ESMO Essentials for Clinicians
OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts,
